All News

A new study on the use of PSA-based prostate cancer screening in the United States has found that many elderly men may be undergoing unnecessary prostate cancer screenings. At the same time, a significant percentage in their fifties are not being screened.

Using the pelvic organ prolapse quantification exam, the Elevate Anterior and Apical Prolapse Repair System (American Medical Systems, Minnetonka, MD) has demonstrated 6-month efficacy rates of stage 1 or less to be 86.3% for anterior and 98.8% for apical prolapse, according to findings from a prospective, multicenter study.

Nearly three-fourths of men who receive androgen deprivation therapy post-radical prostatectomy gain significant weight in the first year, putting on an average of 4.2 kg, according to a recent study.

When clinicians engage men in discussions of treatment for prostate cancer, they should keep in mind the very real impact of obesity on the man's overall prognosis - a risk that for some men may be more significant than that presented by the malignancy.

Cauterizing Hunner's lesions can give huge relief to patients who have them. But there may be another way to get results that may be just as good with somewhat fewer risks-cystoscopic injection of the lesions with the steroid triamcinolone.

Urology drugs and devices that are in the pipeline from Auxilium Pharmaceuticals, Inc., Bavarian Nordic, Antares Pharma, Inc., Endo Pharmaceuticals, Bioniche Life Sciences, Inc., and Pfizer Inc.

Prostate cancer research using whole genome sequencing analysis may lead to the identification of novel therapeutic targets as well as diagnostic tools for identifying aggressive primary tumors and characterizing genomic changes associated with disease progression.

The newest urology products and services from Thermo Fisher, Cardinal Health, Coker Group, and Dale Medical Products, Inc.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. interstitial cystitis trials that are currently recruiting participants as well as phase IV U.S. incontinence/overactive bladder trials. This list is current as of March 11, 2011. For more information, view the complete database at http://ClinicalTrials.gov.